Apimeds Pharmaceuticals US, Inc. Balance Sheet
Apimeds Pharmaceuticals US, Inc.'s total assets for Q3 2025 were $9.25M, a decrease of -12.29% from the previous quarter. APUS total liabilities were $1.09M for the fiscal quarter, a 34.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.